277 related articles for article (PubMed ID: 20574455)
1. Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.
Chen Y; Peng C; Sullivan C; Li D; Li S
Leukemia; 2010 Sep; 24(9):1545-54. PubMed ID: 20574455
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy of chronic myeloid leukemia.
Sullivan C; Peng C; Chen Y; Li D; Li S
Biochem Pharmacol; 2010 Sep; 80(5):584-91. PubMed ID: 20470758
[TBL] [Abstract][Full Text] [Related]
3. Leukemia Stem Cells in Chronic Myeloid Leukemia.
Shan Y; DeSouza N; Qiu Q; Li S
Adv Exp Med Biol; 2019; 1143():191-215. PubMed ID: 31338821
[TBL] [Abstract][Full Text] [Related]
4. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
Chen Y; Li D; Li S
Cell Cycle; 2009 Nov; 8(21):3488-92. PubMed ID: 19823023
[TBL] [Abstract][Full Text] [Related]
5. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.
Hu Y; Swerdlow S; Duffy TM; Weinmann R; Lee FY; Li S
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16870-5. PubMed ID: 17077147
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
Hu Y; Chen Y; Douglas L; Li S
Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
[TBL] [Abstract][Full Text] [Related]
7. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
8. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.
Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M
Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012
[TBL] [Abstract][Full Text] [Related]
9. Induction of Chronic Myeloid Leukemia in Mice.
Zhang H; Li S
Methods Mol Biol; 2016; 1465():17-25. PubMed ID: 27581135
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
11. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cancer stem cells in chronic myeloid leukaemia.
Jørgensen HG; Holyoake TL
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
Jin B; Wang C; Li J; Du X; Ding K; Pan J
Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells.
Zhang H; Li S
Protein Cell; 2013 Mar; 4(3):186-96. PubMed ID: 23483480
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic agents against cancer stem cells of chronic myeloid leukemia.
Chen Y; Peng C; Sullivan C; Li D; Li S
Anticancer Agents Med Chem; 2010 Feb; 10(2):111-5. PubMed ID: 20184539
[TBL] [Abstract][Full Text] [Related]
16. Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib.
Jin Y; Yao Y; Chen L; Zhu X; Jin B; Shen Y; Li J; Du X; Lu Y; Jiang S; Pan J
Theranostics; 2016; 6(11):1947-62. PubMed ID: 27570562
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia stem cells.
Kavalerchik E; Goff D; Jamieson CH
J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
[TBL] [Abstract][Full Text] [Related]
18. New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in chronic myeloid leukemia.
Stefanachi A; Leonetti F; Nicolotti O; Catto M; Pisani L; Cellamare S; Altomare C; Carotti A
Curr Cancer Drug Targets; 2012 Jun; 12(5):571-96. PubMed ID: 22414010
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Clarkson B; Strife A; Wisniewski D; Lambek CL; Liu C
Leukemia; 2003 Jul; 17(7):1211-62. PubMed ID: 12835715
[TBL] [Abstract][Full Text] [Related]
20. Leukemia stem cells: the root of chronic myeloid leukemia.
Zhou H; Xu R
Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
